AllianceBernstein’s Denali Therapeutics DNLI Stock Holding History

AllianceBernstein’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$43.9M	Sell	3,137,140 -17,247	-0.5%	-$241K	0.01%	638
2025 Q1	$42.9M	Sell	3,154,387 -161,255	-5%	-$2.19M	0.02%	627
2024 Q4	$67.6M	Buy	3,315,642 +268,378	+9%	+$5.47M	0.02%	514
2024 Q3	$88.8M	Buy	3,047,264 +1,028,730	+51%	+$30M	0.03%	456
2024 Q2	$46.9M	Buy	2,018,534 +1,880,914	+1,367%	+$43.7M	0.02%	611
2024 Q1	$2.82M	Sell	137,620 -2,340	-2%	-$48K	﹤0.01%	1729
2023 Q4	$3M	Buy	139,960 +3,200	+2%	+$68.7K	﹤0.01%	1723
2023 Q3	$2.82M	Sell	136,760 -41,960	-23%	-$866K	﹤0.01%	1687
2023 Q2	$5.27M	Buy	178,720 +8,560	+5%	+$253K	﹤0.01%	1409
2023 Q1	$3.92M	Buy	170,160 +15,200	+10%	+$350K	﹤0.01%	1499
2022 Q4	$4.31M	Hold	154,960	–	–	﹤0.01%	1498
2022 Q3	$4.76M	Hold	154,960	–	–	﹤0.01%	1418
2022 Q2	$4.56M	Hold	154,960	–	–	﹤0.01%	1491
2022 Q1	$4.99M	Buy	154,960 +300	+0.2%	+$9.65K	﹤0.01%	1577
2021 Q4	$6.9M	Hold	154,660	–	–	﹤0.01%	1440
2021 Q3	$7.8M	Sell	154,660 -700	-0.5%	-$35.3K	﹤0.01%	1374
2021 Q2	$12.2M	Buy	155,360 +58,760	+61%	+$4.61M	﹤0.01%	1127
2021 Q1	$5.52M	Buy	96,600 +700	+0.7%	+$40K	﹤0.01%	1498
2020 Q4	$8.03M	Buy	95,900 +2,700	+3%	+$226K	﹤0.01%	1231
2020 Q3	$3.34M	Sell	93,200 -2,200	-2%	-$78.8K	﹤0.01%	1566
2020 Q2	$2.31M	Buy	95,400 +24,000	+34%	+$580K	﹤0.01%	1753
2020 Q1	$1.25M	Buy	71,400 +400	+0.6%	+$7K	﹤0.01%	1923
2019 Q4	$1.24M	Hold	71,000	–	–	﹤0.01%	2178
2019 Q3	$1.09M	Hold	71,000	–	–	﹤0.01%	2202
2019 Q2	$1.47M	Buy	71,000 +1,600	+2%	+$33.2K	﹤0.01%	2133
2019 Q1	$1.61M	Hold	69,400	–	–	﹤0.01%	2015
2018 Q4	$1.43M	Buy	69,400 +17,000	+32%	+$351K	﹤0.01%	2009
2018 Q3	$1.14M	Buy	52,400 +27,000	+106%	+$587K	﹤0.01%	2249
2018 Q2	$387K	Buy	+25,400	New	+$387K	﹤0.01%	2697